<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BNU-China_Background skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:BNU-China/Background</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Team:BNU-CHINA - 2016.igem.org</TITLE>
style = &quot;font-family: Helvetica;&quot;
</P><DIV class="header-container"><NAV class="navbar navbar-fixed-top navbar-inverse nav-adjust" role="navigation" style="margin-top: 14px;"><DIV class="container-fluid nav-container scrolled-top"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" id="navbar-toggle"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON><A class="navbar-brand" id="navbar-brand" href="https://2018.igem.org/Team:BNU-China" style="font-family: Helvetica;">BNU-China</A></DIV><DIV class="collapse navbar-collapse navbar-right" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav"><LI><A href="https://2018.igem.org/Team:BNU-China" class="" style="font-family: Helvetica;">Home</A></LI><LI class="dropdown focus"><A href="https://2018.igem.org/Team:BNU-China/Project" class="dropdown-toggle" data-toggle="dropdown" style="font-family: Helvetica;">Project </A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Background" style="font-family: Helvetica;">Background</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Design" style="font-family: Helvetica;">Design</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Results" style="font-family: Helvetica;">Results</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Improve" style="font-family: Helvetica;">Improvement</A></LI></UL><LI class="dropdown "><A href="#" class="dropdown-toggle" data-toggle="dropdown" style="font-family: Helvetica;">Modeling </A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model#Main" style="font-family: Helvetica;">Main model</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model#Probability" style="font-family: Helvetica;">Probability of distribution</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model#E" style="font-family: Helvetica;">E.coli growth rate</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model#Growth" style="font-family: Helvetica;">Growth promoting effect</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model#Gene" style="font-family: Helvetica;">Gene expression level</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model#Ribosome" style="font-family: Helvetica;">Ribosome fall-off rate</A></LI><LI class="dropdown "><A href="./achievement.html" class="dropdown-toggle" data-toggle="dropdown" style="font-family: Helvetica;">Achievements </A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Measurement" style="font-family: Helvetica;">Measurement</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Demonstrate" style="font-family: Helvetica;">Demonstrate</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Judging" style="font-family: Helvetica;">Judging</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Parts" style="font-family: Helvetica;">Parts</A></LI><LI class="dropdown "><A href="#" class="dropdown-toggle" data-toggle="dropdown" style="font-family: Helvetica;">Human Practices </A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Human_Practices#Overview" style="font-family: Helvetica;">Overview</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Human_Practices#Silver" style="font-family: Helvetica;">Silver</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Human_Practices#Gold" style="font-family: Helvetica;">Gold</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Human_Practices#Social Activities" style="font-family: Helvetica;">Social Activities</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Human_Practices#Public " style="font-family: Helvetica;">Public Engagement</A></LI><LI class=""><A href="https://2018.igem.org/Team:BNU-China/Safety" style="font-family: Helvetica;">Safety</A></LI><LI class="dropdown "><A href="#" class="dropdown-toggle" data-toggle="dropdown" style="font-family: Helvetica;">Team </A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Team#" style="font-family: Helvetica;">Members</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Attributions" style="font-family: Helvetica;">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Collaborations" style="font-family: Helvetica;">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Acknowledgement" style="font-family: Helvetica;">Acknowledgement</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Notebook" style="font-family: Helvetica;">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Protocol" style="font-family: Helvetica;">Protocol</A></LI><LI class="dropdown "><A href="https://2018.igem.org/Team:BNU-China/InterLab" class="dropdown-toggle" data-toggle="dropdown" style="font-family: Helvetica;">InterLab </A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/InterLab#Calibration" style="font-family: Helvetica;">Calibration</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/InterLab#Cell Measurement" style="font-family: Helvetica;">Cell measurement</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/InterLab#CFU Measurement" style="font-family: Helvetica;">CFU measurement</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/InterLab#Epilogue" style="font-family: Helvetica;"> Epilogue</A></LI></DIV></DIV></NAV></DIV><DIV class="main-container"><DIV class="page-story"><ARTICLE id="project" class="col-lg-10 col-lg-offset-1 col-md-12 col-md-offset-0 col-sm-offset-0 col-sm-12"><HEADER class="page-header"><H1>Background</H1></HEADER><P>Using plasmids as vectors to introduce foreign genes into engineered bacteria is the most common approach in genetic engineering. But plasmids in microbiology are unstable, which is major due to distribution instability and structural instability:</P><P>(1) Structural instability: Generally, foreign genes are not necessary for engineered bacteria, which means whether the foreign genes are functional, the host can still survive, so the unfavorable mutations would gradually accumulate leading to strain degeneration. Meanwhile, plasmids in bacteria could be in many forms. Some  can be integrated into genomes of the host by homologous recombinases.</P><P>(2) Distribution instability: there is usually no mechanism to guarantee the average distribution of plasmids during division, so the genes in exogenous  plasmids do not have genetic stability.</P><P>The degradation of engineered bacteria is essentially caused by growth rate. Degraded strains have more growth advantages than the non-degraded ones because of the additional metabolic burden taken by plasmids or the toxic substance expressed by foreign genes.Therefore the more copies of the plasmids or the higher expression of the toxic protein, bacteria grow slower. On the contrary, the bacteria with low copy number, no plasmid or whose plasmids loss functiongrow faster than that of non-degraded strains. Eventually, in the whole population of bacteria, degradation strains accumulate more and more, and functional strains less and less.</P><FIGURE class="text-center"><FIGCAPTION>
                    Fig.1 Degradation of engineered bacteria
                </FIGCAPTION></FIGURE><P>Currently, the conventional method is to add a resistant gene expresses independently into the plasmids. Bacteria with low or no copies of plasmids will be killed or suppressed when antibiotics were added into the culture, while strains with high copies retained. This method is widely used in the laboratory. However, there are some disadvantages:</P><P>(1) The problem of structural instability of plasmids cannot be solved. After the target gene loses its function, the resistant gene can still be expressed smoothly, which leads to that the bacteria screened by the resistant environment are not thoroughly.</P><P>(2) The application of this method is restricted. It could be used in the laboratory, but there would be a huge cost due to the using of antibiotics in industry;</P><P>(3) Those bacteria with resistant genes will metabolize antibiotics, so the concentration of antibiotics in the culture would gradually reduce, which is not conducive to long-term experiments.</P><P>(4) Adding antibiotics to the culture is exactly adding selection pressure, so a large part of energy is use to fight against those survival pressure, which leads to relatively low expression of target genes in engineered bacteria.</P><P>To sum up, the use of antibiotics in the construction, screening and application of engineered bacteria can NOT be avoided, and there are also many problems. In this summer, BNU-china are devoted to explore a novel method to fight against plasmids loss in the environment without antibiotics, and hope that our efforts could finally change the world.</P></ARTICLE></DIV><DIV id="footer"><DIV id="footer-div"><UL id="footer-ul"><LI><A href="https://2018.igem.org/Team:BNU-China">Home</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Background">Project</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Model">Modeling</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Achievements">Achievements</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Safety">Safety</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/Team">Team</A></LI><LI><A href="https://2018.igem.org/Team:BNU-China/InterLab">InterLab</A></LI></UL><SPAN>© 2018 BNU</SPAN></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>